Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 7 studies | 25% ± 6% | |
glutamatergic neuron | 4 studies | 33% ± 19% | |
interneuron | 4 studies | 43% ± 21% | |
GABAergic neuron | 4 studies | 44% ± 17% |
Insufficient scRNA-seq data for expression of CFAP161 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 126.64 | 575 / 578 | 19% | 0.62 | 223 / 1155 |
thymus | 95% | 19.96 | 619 / 653 | 10% | 0.30 | 63 / 605 |
brain | 88% | 41.72 | 2319 / 2642 | 15% | 0.87 | 106 / 705 |
breast | 89% | 14.72 | 407 / 459 | 7% | 0.17 | 83 / 1118 |
uterus | 86% | 25.22 | 146 / 170 | 7% | 0.50 | 34 / 459 |
spleen | 90% | 15.54 | 216 / 241 | 0% | 0 | 0 / 0 |
adipose | 88% | 14.74 | 1058 / 1204 | 0% | 0 | 0 / 0 |
heart | 87% | 14.67 | 753 / 861 | 0% | 0 | 0 / 0 |
ovary | 51% | 4.77 | 91 / 180 | 32% | 1.29 | 139 / 430 |
peripheral blood | 72% | 18.74 | 670 / 929 | 0% | 0 | 0 / 0 |
kidney | 67% | 8.91 | 60 / 89 | 3% | 0.06 | 27 / 901 |
esophagus | 56% | 5.71 | 815 / 1445 | 7% | 0.10 | 13 / 183 |
pancreas | 58% | 5.86 | 189 / 328 | 5% | 0.12 | 9 / 178 |
prostate | 58% | 6.33 | 142 / 245 | 2% | 0.07 | 11 / 502 |
liver | 55% | 6.19 | 125 / 226 | 3% | 0.05 | 11 / 406 |
bladder | 52% | 5.95 | 11 / 21 | 5% | 0.10 | 23 / 504 |
blood vessel | 54% | 5.59 | 724 / 1335 | 0% | 0 | 0 / 0 |
intestine | 48% | 4.47 | 464 / 966 | 5% | 0.10 | 24 / 527 |
skin | 43% | 3.86 | 769 / 1809 | 10% | 0.39 | 46 / 472 |
stomach | 47% | 4.65 | 168 / 359 | 5% | 0.12 | 13 / 286 |
adrenal gland | 36% | 3.16 | 94 / 258 | 4% | 0.08 | 10 / 230 |
muscle | 13% | 0.95 | 101 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.02 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0060271 | Biological process | cilium assembly |
GO_0160111 | Cellular component | axonemal A tubule inner sheath |
GO_0005879 | Cellular component | axonemal microtubule |
GO_0031514 | Cellular component | motile cilium |
GO_0005515 | Molecular function | protein binding |
Gene name | CFAP161 |
Protein name | Cilia and flagella associated protein 161 Cilia- and flagella-associated protein 161 |
Synonyms | C15orf26 |
Description | FUNCTION: Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating. . |
Accessions | ENST00000561216.1 H0YM05 ENST00000286732.5 [Q6P656-1] ENST00000560091.5 H0YNS7 Q6P656 |